{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:13:28Z","timestamp":1787022808358,"version":"build-2736575974"},"reference-count":56,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":327,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Subclinical hypothyroidism (SCH) is diagnosed when thyroid function tests show that the serum thyrotropin (TSH) level is elevated and the serum free thyroxine (FT4) level is normal. SCH is mainly caused by Hashimoto\u2019s thyroiditis, the prevalence of which increases with aging. Recently, it has been revealed that SCH is associated with risk factors for cardiovascular diseases (CVDs), including atherosclerosis, dyslipidemia and hypertension, leading to cardiovascular morbidity and mortality. However, there are still controversies regarding the diagnosis and treatment of SCH in elderly patients. In this review, we present recent evidence regarding the relationship between SCH and CVD and treatment recommendations for SCH, especially in elderly patients. Studies have shown that SCH is associated with CVD and all-cause mortality. Patients aged less than 65 years showed significant associations of SCH with CVD risk and all-cause mortality, whereas patients aged 65 or older did not show such associations. It was shown that levothyroxine therapy was associated with lower all-cause mortality and cardiovascular mortality in younger SCH patients (&amp;lt;65\u201370 years) but not in SCH patients aged 65\u201370 years or older. In elderly SCH patients, levothyroxine treatment should be considered individually according to the patient\u2019s age, serum TSH level, hypothyroid symptoms, CVD risk and other comorbidities. To further elucidate the impact of SCH on CVD in elderly patients, studies should be conducted using age-specific reference ranges of results of thyroid function tests, focusing on elderly patients, specific serum TSH levels, thyroid antibody status and cardiovascular risk factors.<\/jats:p>","DOI":"10.1530\/ec-24-0601","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T08:24:06Z","timestamp":1742459046000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":7,"title":["Is subclinical hypothyroidism associated with cardiovascular disease in the elderly?"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9571-1646","authenticated-orcid":true,"given":"Koichiro","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , ,","place":["Okayama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , ,","place":["Okayama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Soejima","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , ,","place":["Okayama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhito","family":"Suyama","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , ,","place":["Okayama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Oguni","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , ,","place":["Okayama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kou","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , ,","place":["Okayama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7014-9095","authenticated-orcid":true,"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , ,","place":["Okayama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"2026070710582120800_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.2019.9052","article-title":"Subclinical hypothyroidism: a review","volume":"322","author":"Biondi","year":"2019","journal-title":"JAMA"},{"key":"2026070710582120800_bib2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"key":"2026070710582120800_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-022-00357-7","article-title":"Hypothyroidism","volume":"8","author":"Chaker","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"2026070710582120800_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-8587(21)00285-0","article-title":"Subclinical hypothyroidism in older individuals","volume":"10","author":"Biondi","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070710582120800_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1408684","article-title":"Hypothyroidism and metabolic cardiovascular disease","volume":"15","author":"Patrizio","year":"2024","journal-title":"Front Endocrinol"},{"key":"2026070710582120800_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20745","article-title":"Association of subclinical hypothyroidism and cardiovascular disease with mortality","volume":"3","author":"Inoue","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026070710582120800_bib7","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1210\/jc.2009-1749","article-title":"The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort","volume":"95","author":"Razvi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","article-title":"Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study","volume":"132","author":"Hak","year":"2000","journal-title":"Ann Intern Med"},{"key":"2026070710582120800_bib9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1507\/endocrj.EJ22-0182","article-title":"Update on subclinical thyroid dysfunction","volume":"69","author":"Hashimoto","year":"2022","journal-title":"Endocr J"},{"key":"2026070710582120800_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/thy.2017.0414","article-title":"Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies","volume":"28","author":"Moon","year":"2018","journal-title":"Thyroid"},{"key":"2026070710582120800_bib11","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1210\/jc.2011-3047","article-title":"The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study","volume":"97","author":"Somwaru","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib12","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.1210\/clinem\/dgad623","article-title":"Incidence and determinants of spontaneous normalization of subclinical hypothyroidism in older adults","volume":"109","author":"van der Spoel","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib13","first-page":"553","article-title":"Changes in serum biochemical markers in relation to chief complaints and aging in general medicine","volume":"72","author":"Omura","year":"2018","journal-title":"Acta Med Okayama"},{"key":"2026070710582120800_bib14","first-page":"7","article-title":"Aging-related characteristics of subclinical hypothyroidism detected in general practice","volume":"76","author":"Takami","year":"2022","journal-title":"Acta Med Okayama"},{"key":"2026070710582120800_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/nu16010087","article-title":"Subclinical hypothyroidism in patients with obesity and metabolic syndrome: a narrative review","volume":"16","author":"Biondi","year":"2023","journal-title":"Nutrients"},{"key":"2026070710582120800_bib16","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac016","article-title":"Meta-analysis on the association between thyroid hormone disorders and arterial stiffness","volume":"6","author":"Bernardi","year":"2022","journal-title":"J Endocr Soc"},{"key":"2026070710582120800_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13044-024-00199-3","article-title":"Increased thyroid stimulating hormone (TSH) as a possible risk factor for atherosclerosis in subclinical hypothyroidism","volume":"17","author":"Alomair","year":"2024","journal-title":"Thyroid Res"},{"key":"2026070710582120800_bib18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fendo.2019.00888","article-title":"Hypothyroidism: cardiovascular endpoints of thyroid hormone replacement","volume":"10","author":"Stamatouli","year":"2019","journal-title":"Front Endocrinol"},{"key":"2026070710582120800_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2012.10.070","article-title":"Carotid intima-media thickness in patients with subclinical hypothyroidism: a meta-analysis","volume":"227","author":"Gao","year":"2013","journal-title":"Atherosclerosis"},{"key":"2026070710582120800_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016053","article-title":"Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis","volume":"7","author":"Zhao","year":"2017","journal-title":"BMJ Open"},{"key":"2026070710582120800_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5551\/jat.39917","article-title":"Effect of thyroxin treatment on carotid intima-media thickness (CIMT) reduction in patients with subclinical hypothyroidism (SCH): a meta-analysis of clinical trials","volume":"24","author":"Aziz","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"2026070710582120800_bib22","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jc.2018-00279","article-title":"Impact of thyroid hormone therapy on atherosclerosis in the elderly with subclinical hypothyroidism: a randomized trial","volume":"103","author":"Blum","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.12659\/MSM.891163","article-title":"Alteration of lipid profile in subclinical hypothyroidism: a meta-analysis","volume":"20","author":"Xu","year":"2014","journal-title":"Med Sci Monit"},{"key":"2026070710582120800_bib24","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jcem.86.10.7973","article-title":"TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study)","volume":"86","author":"Meier","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jcem.87.4.8378","article-title":"Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study","volume":"87","author":"Caraccio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102204","article-title":"Systematic review and meta-analysis of levothyroxine effect on blood pressure in patients with subclinical hypothyroidism","volume":"49","author":"Darouei","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"2026070710582120800_bib27","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1603825","article-title":"Thyroid hormone therapy for older adults with subclinical hypothyroidism","volume":"376","author":"Stott","year":"2017","journal-title":"N Engl J Med"},{"key":"2026070710582120800_bib28","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1210\/jcem.84.6.5733","article-title":"Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism","volume":"84","author":"Biondi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.591588","article-title":"Levothyroxine for the treatment of subclinical hypothyroidism and cardiovascular disease","volume":"11","author":"Sue","year":"2020","journal-title":"Front Endocrinol"},{"key":"2026070710582120800_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1162626","article-title":"Low glomerular filtration rate values are associated with higher TSH in an elderly population at high cardiovascular disease risk","volume":"14","author":"Brenta","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026070710582120800_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/105072503322238863","article-title":"Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey","volume":"13","author":"Lindeman","year":"2003","journal-title":"Thyroid"},{"key":"2026070710582120800_bib32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/thy.2010.0298","article-title":"Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study","volume":"21","author":"McQuade","year":"2011","journal-title":"Thyroid"},{"key":"2026070710582120800_bib33","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1210\/jc.2014-1250","article-title":"Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis","volume":"99","author":"Collet","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2018.03.371","article-title":"Relation of subclinical hypothyroidism is associated with cardiovascular events and all-cause mortality in adults with high cardiovascular risk","volume":"122","author":"Moon","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026070710582120800_bib35","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid status, cardiovascular risk, and mortality in older adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"key":"2026070710582120800_bib36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jc.2012-2180","article-title":"Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study","volume":"98","author":"Hyland","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib37","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","article-title":"Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts","volume":"126","author":"Gencer","year":"2012","journal-title":"Circulation"},{"key":"2026070710582120800_bib38","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2011-1978","article-title":"Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk","volume":"97","author":"Nanchen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib39","doi-asserted-by":"crossref","first-page":"e1847","DOI":"10.1210\/clinem\/dgae001","article-title":"Association of thyroid dysfunction in individuals \u2265 65 Years of age with subclinical cardiac abnormalities","volume":"109","author":"Barasch","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001159","article-title":"Prognostic role of hypothyroidism in heart failure: a meta-analysis","volume":"94","author":"Ning","year":"2015","journal-title":"Medicine"},{"key":"2026070710582120800_bib41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archinternmed.2012.1159","article-title":"Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality","volume":"172","author":"Razvi","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026070710582120800_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129793","article-title":"Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality","volume":"10","author":"Andersen","year":"2015","journal-title":"PLoS One"},{"key":"2026070710582120800_bib43","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2016-2226","article-title":"Long-term outcome in levothyroxine treated patients with subclinical hypothyroidism and concomitant heart disease","volume":"101","author":"Andersen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.674841","article-title":"Levothyroxine treatment and cardiovascular outcomes in older people with subclinical hypothyroidism: pooled individual results of two randomised controlled trials","volume":"12","author":"Zijlstra","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070710582120800_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1210\/clinem\/dgaa777","article-title":"Association of thyroid hormone therapy with mortality in subclinical hypothyroidism: a systematic review and meta-analysis","volume":"106","author":"Peng","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710582120800_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13643-024-02548-7","article-title":"Cardiovascular and bone health outcomes in older people with subclinical hypothyroidism treated with levothyroxine: a systematic review and meta-analysis","volume":"13","author":"Holley","year":"2024","journal-title":"Syst Rev"},{"key":"2026070710582120800_bib47","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.amjmed.2020.01.018","article-title":"The impact of levothyroxine on cardiac function in older adults with mild subclinical hypothyroidism: a randomized clinical trial","volume":"133","author":"Gencer","year":"2020","journal-title":"Am J Med"},{"key":"2026070710582120800_bib48","article-title":"Effects of levothyroxine in subclinical hypothyroidism and heart failure with reduced ejection fraction: an open-label randomized trial","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"key":"2026070710582120800_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000356507","article-title":"2013 ETA guideline: management of subclinical hypothyroidism","volume":"2","author":"Pearce","year":"2013","journal-title":"Eur Thyroid J"},{"key":"2026070710582120800_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1590\/S0004-27302013000400003","article-title":"Clinical practice guidelines for the management of hypothyroidism","volume":"57","author":"Brenta","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"2026070710582120800_bib51","article-title":"Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline","volume":"365","author":"Bekkering","year":"2019","journal-title":"BMJ"},{"key":"2026070710582120800_bib52","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/thy.2023.0169","article-title":"Thyroid stimulating hormone and thyroid hormones (triiodothyronine and thyroxine): an American thyroid association-commissioned review of current clinical and laboratory status","volume":"33","author":"Van Uytfanghe","year":"2023","journal-title":"Thyroid"},{"key":"2026070710582120800_bib53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2016.12.008","article-title":"Prevalence of thyroid dysfunction and autoimmunity in the older population and implications of age-specific reference ranges","volume":"465","author":"Veltri","year":"2017","journal-title":"Clin Chim Acta"},{"key":"2026070710582120800_bib54","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1089\/thy.2017.0715","article-title":"An age-specific serum thyrotropin reference range for the diagnosis of thyroid diseases in older adults: a cross-sectional survey in China","volume":"28","author":"Zhai","year":"2018","journal-title":"Thyroid"},{"key":"2026070710582120800_bib55","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/thy.2009.0205","article-title":"Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters","volume":"19","author":"Kasagi","year":"2009","journal-title":"Thyroid"},{"key":"2026070710582120800_bib56","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/5\/EC-24-0601.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/5\/EC-24-0601.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0601\/9431\/ec-24-0601.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0601\/9431\/ec-24-0601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:23:23Z","timestamp":1783437803000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/14\/5\/e240601\/1383\/Is-subclinical-hypothyroidism-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-24-0601","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"article-number":"e240601"}}